BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22160565)

  • 1. Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands.
    Cremers R; van Asperen C; Kil P; Vasen H; Wiersma T; van Oort I; Kiemeney L
    Fam Cancer; 2012 Jun; 11(2):195-200. PubMed ID: 22160565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes Toward and Use of Prostate-Specific Antigen Testing Among Urologists and General Practitioners in Germany: A Survey.
    Kappen S; Jürgens V; Freitag MH; Winter A
    Front Oncol; 2021; 11():691197. PubMed ID: 34150662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General practitioners' approaches to prostate-specific antigen testing in the north-east of the Netherlands.
    Kappen S; Koops L; Jürgens V; Freitag MH; Blanker MH; Timmer A; de Bock GH
    BMC Fam Pract; 2020 Dec; 21(1):270. PubMed ID: 33334312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
    Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
    BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: results of a representative cross-sectional questionnaire study of general practitioners and internal specialists.
    Gilfrich C; May M; Braun KP; Lebentrau S; Lehsnau M; Ecke T; Schmailzl KJ; Al-Dumaini S; Hallmann S; Ahmed AM; Maurer J; Karl T; Braun V; Haferkamp A; Brookman-May S; Bauer RM; Stief CG; Hoschke B; Maurer O; Wolff I
    Urol Int; 2014; 93(2):160-9. PubMed ID: 24603136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of prostate cancer using prostate-specific antigen testing: an empirical evaluation among general practitioners and urologists.
    Kappen S; Jürgens V; Freitag MH; Winter A
    Cancer Manag Res; 2019; 11():3079-3097. PubMed ID: 31114352
    [No Abstract]   [Full Text] [Related]  

  • 8. Compliance with biopsy recommendations of a prostate cancer risk calculator.
    van Vugt HA; Roobol MJ; Busstra M; Kil P; Oomens EH; de Jong IJ; Bangma CH; Steyerberg EW; Korfage I
    BJU Int; 2012 May; 109(10):1480-8. PubMed ID: 21933335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study.
    Scherer TP; Saba K; Wettstein MS; Lucca I; Mortezavi A; Waisbrod S; Aujesky D; Capaul R; Strebel RT
    Swiss Med Wkly; 2023 Sep; 153():40115. PubMed ID: 37774392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urologists' personal feelings on PSA screening and prostate cancer treatment.
    Wenzler DL; Rosenberg BH
    J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial.
    Carbunaru S; Sun Z; McCall C; Ofori B; Marshall N; Wang H; Abern M; Liu L; Hollowell CMP; Sharifi R; Vidal P; Kajdacsy-Balla A; Sekosan M; Ferrer K; Wu S; Gallegos M; Gann PH; Moreira D; Sharp LK; Ferrans CE; Murphy AB
    Cancer Med; 2023 Oct; 12(19):19690-19700. PubMed ID: 37787097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A test of knowledge about prostate cancer screening. Online pilot evaluation among Southern California Physicians.
    Bell DS; Hays RD; Hoffman JR; Day FC; Higa JK; Wilkes MS
    J Gen Intern Med; 2006 Apr; 21(4):310-4. PubMed ID: 16499545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study.
    Clements A; Watson E; Rai T; Bukach C; Shine B; Austoker J
    BMC Fam Pract; 2007 Jun; 8():35. PubMed ID: 17593306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners.
    Van der Meer S; Kollen BJ; Hirdes WH; Steffens MG; Hoekstra-Weebers JE; Nijman RM; Blanker MH
    BJU Int; 2013 Jul; 112(1):26-31. PubMed ID: 23465178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPs views and understanding of PSA testing, screening and early detection; survey.
    Sutton J; Melia J; Kirby M; Graffy J; Moss S
    Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
    Drummond FJ; Carsin AE; Sharp L; Comber H
    BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer testing: a snapshot of the attitudes and practice of Australian general practitioners.
    Crowe J; Wootten AC; Howard N
    Aust J Prim Health; 2015; 21(1):111-4. PubMed ID: 24176263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil.
    Wroclawski ML; Amaral BS; Kayano PP; Busato WFS; Westphal SJ; Montagna E; Bianco B; Soares A; Maluf FC; Lemos GC; Carneiro A
    BMC Urol; 2022 Jun; 22(1):86. PubMed ID: 35706024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.
    Roobol MJ; van Vugt HA; Loeb S; Zhu X; Bul M; Bangma CH; van Leenders AG; Steyerberg EW; Schröder FH
    Eur Urol; 2012 Mar; 61(3):577-83. PubMed ID: 22104592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.